Microsatellite instability correlates with negative expression of estrogen and progesterone receptors in sporadic breast cancerCALDES, Trinidad; PEREZ-SEGURA, Pedro; TOSAR, Alicia et al.Teratogenesis, carcinogenesis, and mutagenesis. 2000, Vol 20, Num 5, pp 283-291, issn 0270-3211Article

No mutations in the XRCC2 gene in BRCA1/2-negative high-risk breast cancer familiesRODRIGUEZ-LOPEZ, Raquel; OSORIO, Ana; SANCHEZ-PULIDO, Luis et al.International journal of cancer. 2003, Vol 103, Num 1, pp 136-137, issn 0020-7136, 2 p.Article

Alternative Splicing and Molecular Characterization of Splice Site Variants: BRCA1 c.591C>T as a Case StudyDOSIL, Vanesa; TOSAR, Alicia; CANADAS, Carmen et al.Clinical chemistry (Baltimore, Md.). 2010, Vol 56, Num 1, pp 53-61, issn 0009-9147, 9 p.Article

Breast-Cancer Stromal Cells with TP53 Mutations and Nodal MetastasesPATOCS, Attila; LI ZHANG; YAOMIN XU et al.The New England journal of medicine. 2007, Vol 357, Num 25, pp 2543-2551, issn 0028-4793, 9 p.Article

Total-genome analysis of BRCA½-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiationWEBER, Frank; LEI SHEN; FUKINO, Koichi et al.American journal of human genetics. 2006, Vol 78, Num 6, pp 961-972, issn 0002-9297, 12 p.Article

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer familiesROMERO, Atocha; PEREZ-SEGURA, Pedro; TOSAR, Alicia et al.Breast cancer research and treatment. 2011, Vol 129, Num 3, pp 939-946, issn 0167-6806, 8 p.Article

Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinomaRODRIGUEZ -JIMENEZ, Francisco-Javier; CALDES, Trinidad; INIESTA, Pilar et al.Oncology reports. 2007, Vol 17, Num 6, pp 1301-1307, issn 1021-335X, 7 p.Article

International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutationPEIXOTO, Ana; SANTOS, Catarina; THOMASSEN, Mads et al.Breast cancer research and treatment. 2011, Vol 127, Num 3, pp 671-679, issn 0167-6806, 9 p.Article

The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical TestingPHAROAH, Paul D. P; PALMIERI, Rachel T; BECKMANN, Matthias W et al.Clinical cancer research (Print). 2011, Vol 17, Num 11, pp 3742-3750, issn 1078-0432, 9 p.Article

Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriersMILNE, Roger L; OSORIO, Ana; BLANCO, Ignacio et al.Breast cancer research and treatment. 2010, Vol 119, Num 1, pp 221-232, issn 0167-6806, 12 p.Article

Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer familiesGARCIA, Maria J; FERNANDEZ, Victoria; ALONSO, Carmen et al.Breast cancer research and treatment. 2009, Vol 113, Num 3, pp 545-551, issn 0167-6806, 7 p.Article

The variant E233G of the RAD51D gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutationsRODRIGUEZ-LOPEZ, Raquel; OSORIO, Ana; VEGA, Ana et al.International journal of cancer. 2004, Vol 110, Num 6, pp 845-849, issn 0020-7136, 5 p.Article

Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or bothDE LA HOYA, Miguel; FERNANDEZ, Juan M; TOSAR, Alicia et al.JAMA, the journal of the American Medical Association. 2003, Vol 290, Num 7, pp 929-931, issn 0098-7484, 3 p.Article

Prevalence of germline mutations of MLH and MSH2 in hereditary nonpolyposis colorectal cancer families from SpainCALDES, Trinidad; GODINO, Javier; DE LA HOYA, Miguel et al.International journal of cancer. 2002, Vol 98, Num 5, pp 774-779, issn 0020-7136Article

Analysis of the Oxidative Damage Repair Genes NUDT1, OGG1, and MUTYH in Patients from Mismatch Repair Proficient HNPCC Families (MSS-HNPCC)GARRE, Pilar; BRICENO, Verónica; LLOR, Xavier et al.Clinical cancer research (Print). 2011, Vol 17, Num 7, pp 1701-1712, issn 1078-0432, 12 p.Article

Evidence for a link between TNFRSF11A and risk of breast cancerBONIFACI, Núria; PALAFOX, Marta; BARILE, Monica et al.Breast cancer research and treatment. 2011, Vol 129, Num 3, pp 947-954, issn 0167-6806, 8 p.Article

Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersANTONIOU, Antonis C; SPURDLE, Amanda B; HOFMANN, Wera et al.American journal of human genetics. 2008, Vol 82, Num 4, pp 937-948, issn 0002-9297, 12 p.Article

Mutant BRCA1 alleles transmission: Different approaches and different biasesDE LA HOYA, Miguel; MEIJERS-HEIJBOER, Hanne; DEVILEE, Peter et al.International journal of cancer. 2005, Vol 113, Num 1, pp 166-167, issn 0020-7136, 2 p.Article

Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutationsOSORIO, Ana; DE LA HOYA, Miguel; BENITEZ, Javier et al.European journal of human genetics. 2003, Vol 11, Num 6, pp 489-492, issn 1018-4813, 4 p.Article

About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variantsGUTIERREZ-ENRIQUEZ, Sara; BONACHE, Sandra; MONTALBAN, Gemma et al.International journal of cancer (Print). 2014, Vol 134, Num 9, pp 2088-2097, issn 0020-7136, 10 p.Article

Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their originDE GARIBAY, Gorka Ruiz; GUTIERREZ-ENRIQUEZ, Sara; DIAZ-RUBIO, Eduardo et al.Breast cancer research and treatment. 2012, Vol 133, Num 1, pp 273-283, issn 0167-6806, 11 p.Article

Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancerPITTMAN, Alan M; WEBB, Emily; TWISS, Philip et al.Human molecular genetics (Print). 2008, Vol 17, Num 23, pp 3720-3727, issn 0964-6906, 8 p.Article

p53 Genetic abnormalities and P-glycoprotein expression in stump and primary gastric carcinomasOLIVER, Israel; LACUEVA, Javier; CALPENA, Rafael et al.Hepato-gastroenterology. 2007, Vol 54, Num 74, pp 377-381, issn 0172-6390, 5 p.Article

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersPHILLIPS, Kelly-Anne; MILNE, Roger L; BUYS, Saundra S et al.Journal of clinical oncology. 2013, Vol 31, Num 25, pp 3091-3099, issn 0732-183X, 9 p.Article

Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic casesMARTINEZ-DELGADO, Beatriz; YANOWSKY, Kira; ROBLEDO, Mercedes et al.Journal of medical genetics. 2012, Vol 49, Num 5, pp 341-344, issn 0022-2593, 4 p.Article